Related Experiment Videos
Extrapyramidal symptoms in neuroleptic recipients
Agents and Actions. Supplements
|January 1, 1990
Summary
Adverse drug reactions (ADRs) like extrapyramidal motor symptoms (EPMS) are common in psychiatric therapy with neuroleptics (NLs). Haloperidol showed higher EPMS rates than perazine, highlighting the need for careful risk factor analysis.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Research
Background:
- Adverse drug reactions (ADRs) are a significant concern in psychiatric pharmacotherapy.
- The AMUP study (drug surveillance in psychiatry) aimed to assess ADRs in psychiatric patients.
- Neuroleptics (NLs) are commonly used but associated with potential side effects.
Purpose of the Study:
- To continuously assess adverse drug reactions (ADRs) in psychiatric therapy.
- To monitor neuroleptic (NL) use and associated extrapyramidal motor symptoms (EPMS).
- To investigate potential risk factors for EPMS development in psychiatric patients.
Main Methods:
- Intensive Drug Monitoring (IDM) method used.
- 1107 psychiatric patients monitored, 754 receiving neuroleptics (NLs).
- Analysis included patient demographics, diagnoses, drug combinations, and dosages.
Main Results:
- Extrapyramidal motor symptoms (EPMS) observed in 35% of NL patients, often requiring medication changes.
- Parkinsonism, acute dystonia, and akathisia were the most frequent EPMS.
- Haloperidol (high-potency) showed significantly higher EPMS rates (56%) compared to perazine (14%).
Conclusions:
- Polypharmacy, especially neuroleptic combinations, is frequent in psychiatric practice.
- EPMS rates vary significantly between different neuroleptics (e.g., haloperidol vs. perazine).
- Comprehensive analysis of risk factors including age, sex, diagnosis, and drug dosage is crucial for managing EPMS.